The worst performer was IPX:Impax Asset Management which plummeted 25% after St James's Place announced they were taking one of their funds back off IPX. All a bit of a disaster given this was one of the top ranked shares in my magic formula spreadsheet, so I'd bought some more. They are now down by 45% and looking a pretty terrible investment. I guess they are a long term holding and still pay a decent dividend, so I'll hope there's a recovery in share price.
FXPO:Ferrexpo have been zooming up lately, but dropped 12% this week to go 78% down. I suspect they'll drift further after the recent spike.
TLOU:Tlou Energy fell 7% as they continue to drift downwards and remove all chance of me selling before they leave AIM at the end of the month.
ASHM:Ashmore Group dropped 6% for no particular reason.
CAML:Central Asia Metals had been recovering recently, but fell 5% this week despite other copper producers increasing. Typical this came a few weeks after me buying back lots of shares.
SBTX:SkinBioTherapeutics have been making optimistic noises recently, and seem to have some momentum behind them in advance of Croda launching their new ingredient in April. They went up 14% this week to 18.5p. My trading account target is 23.5p which is looking within reach.
Share of the Week is OPTI:Optibiotix which shot up an amazing 27% on absolutely no news whatsoever. It seems good news causes the price to drop, but no news allows it to rise. My AJ Bell ISA holding is on the verge of going back into profit, but my SIPP holding that I want to sell is still 35% down, so I need 21p to become 33p just to break even, and I have other shares at 60p break even.
Here's the ISA and shares portfolio after week 20 of year 10.
| Weekly Change | |||
| Cash | £94.40 | +£91.75 | |
| Portfolio cost | £112,093.83 | +£0 | |
| Portfolio sell value (bid price-commission) | £52,551.81 | (-53.2%) | +£5,134.87 |
| Potential profits | £0 | +£0 | |
| Yr 10 Dividends | £97.54 | +£0 | |
| Yr 10 Interest | £0.44 | +£0 | |
| Yr 10 Profit from sales | £243.66 | +£0 | |
| Yr 10 proj avg monthly profit | £64.98 | (0.9%) | -£5.31 |
| Total Dividends | £12,320.03 | +£0 | |
| Total Interest | £7.24 | +£0 | |
| Total Profit from sales | £18,121.50 | +£0 | |
| Average monthly cash profit | £265.85 | (3.9%) | -£0.62 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Compound performance | 36% | +0% |
I added £100 to my ISA because I'd cocked up and spent my trading account cash last week. It's a problem that my trading account is split between my HL ISA, AJ Bell ISA and AJ Bell dealing account. I need to move it all into my AJ Bell ISA somehow. Keeping track of where the cash is meant to be is a pain.
Very nice indeed, but still a hell of a long way from the injection line.
Well above the trend line. Could we start pulling it back level?
The SIPP looks like this after week 472 overall and week 4 of year 10.
| Weekly Change | ||||
| Cash | £156.60 | -£273.25 | ||
| Portfolio cost | £121,702.36 | +£1,980.54 | ||
| Portfolio sell value (bid price - commission) | £70,806.62 | (-41.8%) | +£2,225.40 | |
| Potential profits | £4,362.74 | -£1,691.25 | ||
| Yr 10 Dividends | £186.61 | +£140.90 | ||
| Yr 10 Interest | £0 | +£0 | ||
| Yr 10 Profit from sales | £1,597.08 | +£1,597.08 | ||
| Yr 10 proj avg monthly profit | £1.908.23 | (28.8%) | +£1,846.11 | |
| Total Dividends | £16,303.26 | +£140.90 | ||
| Total Interest | £12.90 | +£0 | ||
| Total Profit from sales | £18,605.02 | +£1,597.08 | ||
| Average monthly cash profit | £307.72 | (4.6%) | +£15.16 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Compound performance | 42% | +2% |
This account was very busy. I received a wonderful £140 from PAF:Pan African Resources, and cashed in £1,597 profits so potential profits dropped by that plus a little more and the increase in portfolio value was much less than the ISA at £2,225 for the same reason.
My first sale was 25% of my holding in IGG:IG Group because I wanted to get my holding in POLR:Polar Capital above £1,000 before dividend ex-date. I sold 62 IGG shares at 962.951p and made £64.86 (14.3%) profit. That enabled me to buy 130 POLR shares at 540.86p costing £715.07.
Next I decided to sell half of my PAF:Pan African Resources shares from my AJ Bell SIPP because they were up by over 100% and I've had the dividend, meanwhile CMCL:Caledonia Mining have dropped for no good reason and pay a quarterly dividend, so now seemed like a good time to swap some over. I sold 3,200 PAF shares at 37.0435p making £633.17 (114.6%) profit. I bought 116 CMCL shares at 860p costing £1,009.55.
Next I sold half of my holding in III:3i Group, another which is up by over 100%. I wanted to buy TRY:TR Property Investment, again before dividend ex-date. I sold 30 shares in III making £584.33 (118.5%) profit. I bought 383 shares in TRY at 315p costing £1,217.48.
My final sale was a small amount of my larger HL PAF:Pan African Resources holding to allow me to buy FDM:FDM Group, another top magic formula share that's had a bit of a slump recently but may be staging a small recovery. I sold 2,800 PAF shares at 37.179p making £314.72 (41.9%) profit, and bought 343 FDM shares at 319.8398p costing £1,107.54.
Finally there was my monthly investment in FOUR:4imprint where I bought 4 shares at 5057.137p costing £204.80. That completes all my buying of FOUR, and from next month I'll start buying BHP:BHP Group instead.
The profits sent performance for Year 10 of the scale but only increased long term profits by £15 a month, with average return still less than half my target of 10% at 4.6%.
I do believe we're getting very close to the injection line.
Still not far above the trend line, but great to be on the right side of it.
The trading account looks like this after week 438 overall and week 22 of year 9.
JLP:Jubilee Metals dropped 0.1p but SBTX:SkinBioTherapeutics had a great week and increased potential profits by £45 to £76, but I'm holding out for £177. It may even happen before Christmas!
Not really much movement.
Almost touching the trend line. The success of this account is almost entirely dependent on JLP:Jubilee Metals having a massive re-rate, but the institutional seller has been holding the price back for months. One day they will finish selling, after which there should be a snowball effect over this account and a massive one on my SIPP where I intend to sell the lot.
I do believe we're getting very close to the injection line.
Still not far above the trend line, but great to be on the right side of it.
The trading account looks like this after week 438 overall and week 22 of year 9.
| Weekly Change | |||
| Cash | £63.39 | +£0 | |
| Portfolio cost | £2,073.87 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,224.68 | (-40.9%) | +£29.12 |
| Potential profits | £76.88 | +£45.07 | |
| Year 9 Dividends | £0 | +£0 | |
| Year 9 Interest | £0 | +£0 | |
| Year 9 Profit | £0 | +£0 | |
| Yr 8 proj avg monthly profit | £0 | (+0%) | +£0 |
| Dividends | £85.46 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£602.54 | +£0 | |
| Average monthly cash profit | -£5.12 | (-3.0%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
JLP:Jubilee Metals dropped 0.1p but SBTX:SkinBioTherapeutics had a great week and increased potential profits by £45 to £76, but I'm holding out for £177. It may even happen before Christmas!
Not really much movement.
Almost touching the trend line. The success of this account is almost entirely dependent on JLP:Jubilee Metals having a massive re-rate, but the institutional seller has been holding the price back for months. One day they will finish selling, after which there should be a snowball effect over this account and a massive one on my SIPP where I intend to sell the lot.
I don't think what's happening now can count as a Santa rally because nearly all my holdings lost money this week. I'm hoping for something much nicer next week - but need OPTI:Optibiotix to hold firm and not slide back down again.
No comments:
Post a Comment